News

Skanska's Year-End Report 2025 Presentation Details

Skanska's Year-End Report 2025 Presentation Details

Details of Skanska's Year-end Report 2025 Presentation

On February 6, Skanska is set to release its much-anticipated Year-end report for 2025. The report will be available to the public starting at 07:30 am CET, providing insights into the company's performance over the past fiscal year.

Webcast Presentation by Key Executives

The presentation will be delivered by Skanska's President and CEO, Anders Danielsson, alongside CFO Pontus Winqvist. They will host a webcasted press and audio conference beginning at 10:00 am CET from Skanska's headquarters. This is a prime opportunity for stakeholders and the media to gain a detailed understanding of the company's financial outcomes.

Where to Access the Presentation

The live presentation can be accessed through the Skanska investor relations website. Participants can tune in to listen to the conference, where they may also pose questions directly during the session.

Participating in the Audio Conference

For those interested in taking part in the audio conference, there are two ways to connect:

Web Link for Best Audio Quality

Participants are encouraged to join via the HD Audio web link to ensure optimal audio quality. This web link will be provided at the start of the conference for convenience.

Backup Phone Connection

Should participants prefer or need a direct phone connection, several international numbers will be available for connection. Attendees can dial in using the numbers provided to ensure they can participate in the discussion.

One-on-One Meetings with Executives

Post-conference, attendees will have the chance to engage in individual meetings with Anders Danielsson. If you wish to schedule a meeting, please reach out directly. Don’t miss this valuable opportunity to connect with Skanska's leadership.

Contact Information for Inquiries

For any further inquiries regarding the report or the presentation event, attendees can contact the designated representatives from Skanska:

Investor Relations

Antonia Junelind, SVP, can be reached at +46 (0)10 448 62 61.

Communications

Karolina Cederhage, SVP, is available at +46 (0)10 448 08 80 for communications-related inquiries.

Media Relations

Jacob Birkeland, Head of Media Relations, can also be reached for related queries at +46 (0)10 449 19 57, while the direct media line is +46 (0)10 448 88 99.

Availability of Reports

Attendees can download previous releases from the Skanska website, alongside the current Year-end report to stay informed about the company’s activities and performance.

Frequently Asked Questions

What is the date and time of the Year-end report 2025 presentation?

The presentation will take place on February 6 at 10:00 am CET.

How can I access the presentation?

You can access the presentation via the Skanska investor relations website, which will also subsequently host the recorded session.

Who will present the Year-end report?

Anders Danielsson, the President and CEO, and CFO Pontus Winqvist will present the report.

Is there a way to ask questions during the presentation?

Yes, participants will have the opportunity to pose questions during the audio conference.

Can I schedule a meeting with Skanska's executives?

Yes, individual meetings with executives can be arranged by contacting the provided representatives ahead of time.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 35

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 44

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 29

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

CareDx and Dovetail Genomics Forge New Path in Transplant Solutions

Updated Category News Views 79

Partnership to Enhance HLA Typing Technology CareDx, Inc. (NASDAQ: CDNA), renowned for its pioneering precision medicine approach for transplant patients, has recently joined forces with Dovetail Genomics, a recognized leader in genomic solutions. This notable collaboration is set to introduce an Early Access Program designed for HLA laboratories, leveraging a unique...

Continue Reading
Pet Valu Holdings Secures C$150 Million Through Secondary Offering

Updated Category News Views 285

Pet Valu Holdings Hits Milestone with Recent Secondary Offering MARKHAM, Ontario — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), a prominent name in Canadian specialty retailing, has unveiled the successful completion of its secondary bought deal offering. This initiative has generated an impressive C$150 million through the sale of 5,200,000...

Continue Reading
SMCP Settles Legal Proceedings Over 15.9% Stake Dispute

Updated Category News Views 116

Overview of SMCP's Recent Legal Developments In a significant update, SMCP has received confirmation regarding the legal proceedings related to a notable 15.9% stake in its share capital. The London Court of Appeal has denied requests from Dynamic Treasure Group (DTG) to appeal the High Court's decision, which ruled the sale of shares to DTG as invalid. This ruling...

Continue Reading
Grit Real Estate Announces Important AGM Details for Shareholders

Updated Category News Views 91

Grit Real Estate Income Group's Upcoming AGM Grit Real Estate Income Group Limited, a pan-African leader in real estate, has made a significant announcement regarding its forthcoming Annual General Meeting (AGM). This event is set to take place on a Friday, specifically at 14h30 Mauritian time. Although the exact location is specified, the company invites all eligible...

Continue Reading
Petaluma Enriches Pet Nutrition with Dr. Sarah Dodd

Updated Category News Views 271

Petaluma Welcomes Dr. Sarah Dodd as Advisor and Formulator Petaluma, a forward-thinking sustainable pet nutrition company, is excited to announce the addition of Dr. Sarah Dodd as an Advisor and Formulator. Dr. Dodd is a renowned figure in the field of plant-based pet nutrition, bringing with her a wealth of experience to transform pet food for a sustainable and humane...

Continue Reading